(818) 356-8232 info@theacrm.com

Liver Cirrhosis

Below is a sample of existing clinical evidence:
“All patients were terminal state LC (Liver Cirrhosis) patients. Two third in 51 had the ascitis and more than one third had hepatic encephalopathy. After single stem cell therapy using UCBSC (Umbilical Cord Blood Stem Cell), most of the hepatic encephalopathy patients and more than two third of ascitic patients were improved in symptom or responded to medical therapy who were refractory to previous therapy… Stem cell therapy serves for prolongation of the life and improvement of quality of life.”

– “Treatment of the end Stage Liver Cirrhosis by Human Umbilical Cord Blood Stem Cells: Preliminary Results,” Bahk et al, Stem Cells in Clinic and Research, 2011

For further information regarding regenerative medicine, please refer to information provided by American Academy of Integrative Cell Therapy (AAICT).